Korean biotech firm signs $290 million deal with Roche

Published: 2010-01-21 07:00:00

Updated: 2010-01-21 07:00:00

Digital Biotech Co., a local biotech company, said on January 19 that it has signed a $290 million deal with Roche Holding AG to transfer its candidate dementia treatment to the Switzerland based pharmaceutical giant.

A Korean biotech company said that under the agreement, it will transfer its...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK